title: Paclitaxel loaded carrier based biodegradable polymeric implants: Preparation and in vitro characterization.
abstract: The objective of this study was to develop paclitaxel (PTX) loaded poly(ε-caprolactone) (PCL) based tiny implants. β-Cyclodextrin (β-CD) and polyethylene glycol (PEG 6000) were used to enhance solubility and release of the drug in the phosphate buffer saline pH 7.4. Implants were evaluated in terms of color, shape, thickness, surface area, weight, drug content. Developed implants were characterized for their surface morphology (SEM analysis), drug physical state by thermal analysis (DSC studies), crystalline nature (XRD studies) and drug excipients compatibility (FT-IR spectroscopy). Macroscopically all the tiny implants were white in color and cylindrical in shape with smooth surfaces. PTX was entrapped within implants in the polymeric amorphous form. In vitro drug release studies showed prolonged and controlled release of PTX with zero order and Korsmeyer-Peppas model being exhibited. Excipients and method of preparation did not affect chemical stability of PTX.
authors: Department of Pharmaceutics, East West College of Pharmacy, Bangalore 560 091, Karnataka, India.
authors: Jagadeesh G
authors: JG
authors: Hiremath
authors: Nirav S
authors: NS
authors: Khamar
authors: Subhash G
authors: SG
authors: Palavalli
authors: Chetan G
authors: CG
authors: Rudani
authors: Rajeshkumar
authors: R
authors: Aitha
authors: Prasanthkumar
authors: P
authors: Mura
keywords: Implants; Paclitaxel (PTX); Poly(ε-caprolactone); β-Cyclodextrin
references: J Control Release. 2005 Jun 20;105(1-2):52-67
references: 15955366
references: Semin Oncol. 1992 Dec;19(6):646-62
references: 1361079
references: J Mater Sci Mater Med. 2011 Feb;22(2):327-37
references: 21221735
references: Eur J Pharm Sci. 2001 May;13(2):123-33
references: 11297896
references: Ann Pharmacother. 1994 May;28(5 Suppl):S11-4
references: 7915152
references: Oncologist. 1999;4(3):209-24
references: 10394589
references: Int J Pharm. 2002 Mar 20;235(1-2):179-92
references: 11879753
references: Int J Pharm. 2004 Jun 18;278(1):1-23
references: 15158945
references: Drugs. 1994 Nov;48(5):794-847
references: 7530632
references: Acta Biomater. 2010 Jun;6(6):2045-52
references: 19969111
references: AAPS J. 2004 Oct 11;6(3):e27
references: 15760112
references: J Clin Oncol. 1990 Jul;8(7):1263-8
references: 1972736